2002
DOI: 10.1016/s0009-9120(02)00306-5
|View full text |Cite
|
Sign up to set email alerts
|

Determination of myoglobin: comparative evaluation of the new automated VIDASR assay with two other immunoassays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
2

Year Published

2004
2004
2009
2009

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 11 publications
0
5
0
2
Order By: Relevance
“…[10][11][12] There are several commercial approaches to measuring myoglobin in blood, in addition to new strategies that are still in the demonstration phase. [13][14][15][16][17] The most sensitive commercial assay is the two-site enzyme immunoassay marketed by Dade Behring Inc. 10,12,18,19 This immunoassay requires a laboratorysized Stratus Ò CS Stat Fluorimetric Analyser. An evaluation of this system for myoglobin requires a minimum of 3.0 mL of whole blood ($1.7 mL serum) with an analysis time of 2 h. 19 The detection limit of this assay is reported as 56 pM (1 mg/L) (2 SD over zero measurement) with a linear range of 56 pM-50 nM (1.0-900 mg/L).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[10][11][12] There are several commercial approaches to measuring myoglobin in blood, in addition to new strategies that are still in the demonstration phase. [13][14][15][16][17] The most sensitive commercial assay is the two-site enzyme immunoassay marketed by Dade Behring Inc. 10,12,18,19 This immunoassay requires a laboratorysized Stratus Ò CS Stat Fluorimetric Analyser. An evaluation of this system for myoglobin requires a minimum of 3.0 mL of whole blood ($1.7 mL serum) with an analysis time of 2 h. 19 The detection limit of this assay is reported as 56 pM (1 mg/L) (2 SD over zero measurement) with a linear range of 56 pM-50 nM (1.0-900 mg/L).…”
Section: Introductionmentioning
confidence: 99%
“…Le Moigne et al examined the VIDAS system from bioMerieux, based on an enzyme-linked fluorescent immunoassay method, and suggested that this system had equivalent performance to other commercial systems (detection limit 5 ng/ mL, dynamic range 100 ng/mL, precision <5%). 17 Newer academic approaches include a colloidal gold electrochemical system that has not yet demonstrated equivalent performance to commercial systems, although it holds some promise. 16 Other systems rely on improved luminosity from local field effects, and are also relatively unproven -yet holding promise once developed further.…”
Section: Introductionmentioning
confidence: 99%
“…Acute myocardial infarction (AMI) disrupts cardiac cell membranes, releasing intracellular cardiac proteins into the vascular system. Some of these proteins, including myoglobin, creatine kinase (CK)-MB, lactate dehydrogenase (LDH) type 1, and cardiac troponin subunits T and I, have proven useful for diagnosing AMI (1). In many patients with chest pain, the correct diagnosis of myocardial cell injury depends mainly on cardiac markers because the electrocardiogram is often nondiagnostic (2).…”
Section: Introductionmentioning
confidence: 99%
“…A hemostasia garante o funcionamento adequado do organismo humano pelo equilíbrio entre a manutenção do sangue no estado fluído, permitindo que ele flua pela rede circulatória, e a prevenção de perda sanguínea, que ocorre em situações de risco da integridade vascular. Para a normalidade dessas funções é necessário um potente mecanismo pró-coagulante, para a formação de tampões hemostáticos nos locais comprometidos por lesão vascular e um sistema regulatório capaz de limitar a formação de tampões hemostáticos somente para as áreas comprometidas (LE MOIGNE et al, 2002).…”
Section: Sepse E Sistema Hemostáticounclassified
“…Distúrbios ocorridos no equilíbrio entre os sistemas pró-coagulantes e anticoagulantes devido a fatores genéticos ou adquiridos podem causar alterações hemorrágicas ou trombóticas (LE MOIGNE et al, 2002). No estágio inicial do quadro de sepse, células endoteliais e células mononucleares ativadas produzem citocinas próinflamatórias que ativam os fatores mediadores da coagulação.…”
Section: Sepse E Sistema Hemostáticounclassified